Xue Han
Articles
-
Jan 6, 2025 |
dx.doi.org | Xue Han |Boyang Zhang |Hongyi Chen |Min Peng
-
Dec 3, 2024 |
onlinelibrary.wiley.com | Martin Schröder |Lixia Guo |Xue Han
Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
-
Sep 18, 2024 |
onlinelibrary.wiley.com | Xue Han |Chuan He
Comprehensive Summary In the past two decades, the development of asymmetric radical reactions has achieved tremendous progress, which has emerged as a powerful tool for the synthesis of chiral molecules in synthetic chemistry. Among the diverse array of radical processes, the transfer of hydrogen atoms to tertiary carbon radicals offers the potential for constructing chiral tertiary carbon centers in a stereoselective fashion.
-
Mar 27, 2024 |
elifesciences.org | Hong Long Chen |Lijun Sun |Lu Feng |Xue Han
eLife assessment This study provides valuable findings showing the production of IL-22 from intestinal ILC3 during intermittent fasting promotes beigeing of white adipose tissue. The authors provided solid data and mechanistic insight by which IL-22-derived from ILC3 directly induces beigeing.
-
Feb 23, 2024 |
biorxiv.org | Hong Long Chen |Lijun Sun |Lu Feng |Xue Han
AbstractMechanism underlying the metabolic benefit of intermittent fasting remains largely unknown. Here, we reported that intermittent fasting promoted IL-22 production by type 3 innate lymphoid cells (ILC3s) and subsequent beigeing of subcutaneous white adipose tissue. Adoptive transfer of intestinal ILC3s increased beigeing of white adipose tissue in diet-induced-obese mice. Exogenous IL-22 significantly increased the beigeing of subcutaneous white adipose tissue.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →